financetom
Business
financetom
/
Business
/
Exclusive-Anglo American freezes hiring globally after strategy revamp, document shows
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Exclusive-Anglo American freezes hiring globally after strategy revamp, document shows
May 15, 2024 7:31 PM

SYDNEY (Reuters) -Anglo American has frozen hiring globally after its pledge this week to simplify the miner that is the target of a $43 billion bid by Australia's BHP, according to an internal memo issued by Anglo and reviewed by Reuters.

Anglo laid out plans on Tuesday to refocus its company on energy transition metal copper while spinning out or selling its less profitable coal, nickel, diamond and platinum businesses, as it moves to fend off the world's biggest miner.

The London-listed miner has rejected BHP twice, saying its proposals continue to significantly undervalue the company.

"Following yesterday's announcement of our plans to unlock significant value through a simplification of our portfolio ... it is appropriate that we put in place a freeze on the recruitment of all non site-based permanent employees and contractors across all Businesses and Group Functions," People and Organisation Director Monique Carter said in the memo.

"In instances where formal written offers have been made to a candidate, we will honour those commitments however no new offers should be made," Carter said, adding the freeze also applied to consultants beyond those already contracted.

Anglo did not immediately respond to an emailed request for comment.

Australia's mining and energy union said on Wednesday it would seek urgent meetings with Anglo to discuss workers' job security.

Anglo shares closed up 0.2% at 26.48 pounds on Wednesday, below BHP's latest offer of about 27.53 pounds per share.

BHP's options to take over Anglo are narrowing as it approaches a May 22 deadline to lodge a binding offer.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Incyte misses quarterly profit on weak sales of lead drug
Incyte misses quarterly profit on weak sales of lead drug
Apr 30, 2024
April 30 (Reuters) - Incyte Corp ( INCY ) on Tuesday reported first-quarter profit below Wall Street estimates on weak sales of its blood cancer drug Jakafi, sending its shares down 2.4%. The company is working on strengthening its pipeline to counter competition from newly approved drugs, which could impact sales of Jakafi, the company's biggest-selling drug, as it nears...
--Perficient Mulling Potential Sale, Bloomberg Says
--Perficient Mulling Potential Sale, Bloomberg Says
Apr 30, 2024
10:11 AM EDT, 04/30/2024 (MT Newswires) -- Price: 45.17, Change: +1.71, Percent Change: +3.94 ...
Market Chatter: Perficient Said to be Mulling Potential Sale
Market Chatter: Perficient Said to be Mulling Potential Sale
Apr 30, 2024
10:12 AM EDT, 04/30/2024 (MT Newswires) -- Perficient (PRFT) is weighing a potential sale, Bloomberg reported, citing people familiar with the matter. Perficient did not immediately respond to an MT Newswires' request for comment. (Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation....
Timken's Q1 Adjusted Earnings, Net Sales Fall; 2024 Adjusted Earnings Guidance Lifted
Timken's Q1 Adjusted Earnings, Net Sales Fall; 2024 Adjusted Earnings Guidance Lifted
Apr 30, 2024
10:11 AM EDT, 04/30/2024 (MT Newswires) -- Timken (TKR) shares were up 8% in recent Tuesday trading after the company reported Q1 adjusted earnings of $1.77 per diluted share, down from $2.09 a year earlier. Analysts polled by Capital IQ expected $1.52. Net sales for the quarter that ended March 31 was $1.19 billion, down from $1.26 billion a year...
Copyright 2023-2026 - www.financetom.com All Rights Reserved